Active for over 15 years, Project & Communications Ltd invests in the pharmaceutical sector, including the creation of patents and trademarks, research and development of new products belonging to the field of food supplements, as well as medical devices and pharmaceutical products. In addition, although to a
lesser extent, it also works in the search for new business opportunities for third party companies related to the pharmaceutical industry. 

To date, Project & Communications Ltd plays a key role for the GS PHARMA HOLDING LTD group’s companies in the management and development of international trademarks and patents and in the quality control of the products marketed by the group companies.

These activities mainly concern the development and research through universities, the analysis of the active ingredients necessary to ensure the reproducibility and non-toxicity of the transformation into the finished product.

The fields of application of research and development in which it works are:

VASCULAR
UROLOGICAL
ORTHOPAEDIC
ONCOLOGICAL
OPHTHALMOLOGICAL
VETERINARY
DERMATOLOGICAL
VIROLOGICAL

The main partners are:
THE UNIVERSITY OF GENOA
THE UNIVERSITY OF FERRARA
IOM(Oncological Institute) OF CATANIA
HOSPITAL OF MERANO (DEPARTMENT OF INTEGRATED MEDICINE)
IRCCS(Institute for treatment and research) NEUROMED

The research activity produced the following publications:

Chemoprophylaxis and COVID cure (attached publication)

Treatment with ozonated oil in cancer patients with ozonated oil

https://www.mdpi.com/2072-6694/14/5/1174

Formulation comprising ozonated oil for use in
the prevention and/or treatment of leishmaniasis

New publications in other fields of application, new patents and ongoing negotiations with other international centres, especially in the field of oncology, are on the agenda.